(VIANEWS) – Shares of Alnylam Pharmaceuticals (NASDAQ Composite: ALNY) jumped 5.49% to $168.32 at 12:17 EST on Monday, after four successive sessions in a row of losses. NASDAQ Composite is rising 1.39% to $15,448.12, after two consecutive sessions in a row of gains. This seems, up until now, an all-around positive trend trading session today.

Alnylam Pharmaceuticals’s last close was $159.56, 24.74% below its 52-week high of $212.00.


Today’s last reported volume for Alnylam Pharmaceuticals is 371573 which is 39.42% below its average volume of 613403.

Alnylam Pharmaceuticals’s Sales

Alnylam Pharmaceuticals’s sales growth is 74.6% for the ongoing quarter and 46.7% for the next. The company’s growth estimates for the current quarter and the next is 28% and 23.9%, respectively.

Alnylam Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 112.1%, now sitting on 687.53M for the twelve trailing months.


Alnylam Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was a negative 5.99%, a negative 1.05%, and a positive 2.05%, respectively.

Alnylam Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.99% (last week), 2.12% (last month), and 2.05% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Alnylam Pharmaceuticals’s stock is considered to be overbought (>=80).

Alnylam Pharmaceuticals’s Stock Yearly Top and Bottom Value

Alnylam Pharmaceuticals’s stock is valued at $168.32 at 12:17 EST, way under its 52-week high of $212.00 and way higher than its 52-week low of $120.83.

Alnylam Pharmaceuticals’s Moving Average

Alnylam Pharmaceuticals’s value is way under its 50-day moving average of $192.97 and below its 200-day moving average of $173.57.

More news about Alnylam Pharmaceuticals (ALNY).


Please enter your comment!
Please enter your name here